Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02730312
Recruitment Status : Recruiting
First Posted : April 6, 2016
Last Update Posted : May 2, 2019
Sponsor:
Collaborator:
Chiltern International Inc.
Information provided by (Responsible Party):
Xencor, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : August 2019